Praxis Precision Medicines, Inc.
PRAX
$366.81
-$1.65-0.45%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 7.46M | 7.77M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 7.46M | 7.77M |
| Cost of Revenue | 290.71M | 284.30M | 267.12M | 245.90M | 221.98M |
| Gross Profit | -290.71M | -284.30M | -267.12M | -238.43M | -214.22M |
| SG&A Expenses | 87.46M | 73.03M | 59.08M | 54.68M | 57.37M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 378.17M | 357.33M | 326.20M | 300.57M | 279.35M |
| Operating Income | -378.17M | -357.33M | -326.20M | -293.11M | -271.59M |
| Income Before Tax | -339.13M | -326.53M | -303.27M | -273.04M | -251.01M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -339.13 | -326.53 | -303.27 | -273.04 | -251.01 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -339.13M | -326.53M | -303.27M | -273.04M | -251.01M |
| EBIT | -378.17M | -357.33M | -326.20M | -293.11M | -271.59M |
| EBITDA | -378.05M | -357.20M | -326.06M | -292.95M | -271.35M |
| EPS Basic | -12.94 | -13.38 | -13.47 | -12.90 | -12.29 |
| Normalized Basic EPS | -8.19 | -8.47 | -8.54 | -8.26 | -7.87 |
| EPS Diluted | -12.94 | -13.38 | -13.47 | -12.90 | -12.29 |
| Normalized Diluted EPS | -8.19 | -8.47 | -8.54 | -8.26 | -7.87 |
| Average Basic Shares Outstanding | 105.40M | 97.74M | 89.92M | 84.49M | 81.40M |
| Average Diluted Shares Outstanding | 105.40M | 97.74M | 89.92M | 84.49M | 81.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |